Significance of marginally elevated calcitonin levels in micromedullary thyroid cancer

Annals of Surgical Oncology

Volumn 16, Issue 10, 2009, Pages 2960-

  MacHens, Andreas ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; BONE DENSITY CONSERVATION AGENT;

CALCITONIN BLOOD LEVEL; HUMAN; LETTER; POSTOPERATIVE PERIOD; THYROID MEDULLARY CARCINOMA; MEDULLARY CARCINOMA; METABOLISM; NOTE; THYROID TUMOR;

BONE DENSITY CONSERVATION AGENTS; CALCITONIN; CARCINOMA, MEDULLARY; HUMANS; THYROID NEOPLASMS;

EID: 73349101090     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0642-y     Document Type: Letter

References (5)

1. Pillarissetty VG, Katz SC, Ghossein RA, Tuttle M, Shaha AR. Micromedullary thyroid cancer: how micro is truly micro? Ann Surg Oncol. DOI 10.1245/s10434-009-0595; e-pub ahead of print 1 July 2009.
2. Machens A, Schneyer U, Holzhausen HJ, Dralle H. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin levels. J Clin Endocrinol Metab. 2005;90:2029-34.
3. Machens A, Hinze R, Lautenschläger C, Thomusch O, Dralle H. Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery. 2001;129:23-8.
4. Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003;134:946-55.
5. Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg. 2008;95:586-91